LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
36.69
+2.69 (7.91%)
Oct 15, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, LB Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $58. The average 1-year stock price forecast is 58.08% higher than the current stock price, while the lowest is $35 (-4.61%) and the highest is $80 (+118.04%).
Price Target: $58 (+58.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LB Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 7 | 7 | 7 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 8 | 8 | 8 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +63.53% | Oct 12, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $80 | Buy | Reiterates | $80 | +118.04% | Oct 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $65 | Buy | Initiates | $65 | +77.16% | Oct 9, 2026 |
| Roth MKM | Roth MKM | Hold Downgrades $37 → $35 | Hold | Downgrades | $37 → $35 | -4.61% | Oct 5, 2026 |
| Needham | Needham | Buy Initiates $68 | Buy | Initiates | $68 | +85.34% | Oct 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.47
from -3.13
EPS Next Year
-5.13
from -5.47
EPS and Forward PE are based on non-GAAP adjusted numbers.